Rallybio (FRA:33M0) OCF Margin %: -3,763.21% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:33M0 Rallybio Corp FRA:33M0
18 GF Score
Price €13.90
! 5 Warning Signs
View Full Analysis

What is Rallybio OCF Margin %?

Rallybio FRA:33M0 -1.42% 18 OCF Margin % is -3,763.21% as of Mar. 2026. GuruFocus rates FRA:33M0 with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 949 Biotechnology companies, Rallybio ranks worse than 87.57% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Rallybio's Cash Flow from Operations for the three months ended in Mar. 2026 was €-7.98 Mil. Rallybio's Revenue for the three months ended in Mar. 2026 was €0.21 Mil. Therefore, Rallybio's OCF Margin % for the quarter that ended in Mar. 2026 was -3,763.21%.

As of today, Rallybio's current OCF Yield % is -32.09%.

The historical rank and industry rank for Rallybio's OCF Margin % or its related term are showing as below:

FRA:33M0' s OCF Margin % Range Over the Past 10 Years
Min: -7748.74   Med: -5611.73   Max: -3474.71
Current: -3215.15


During the past 7 years, the highest OCF Margin % of Rallybio was -3474.71%. The lowest was -7748.74%. And the median was -5611.73%.

FRA:33M0's OCF Margin % is ranked worse than
87.57% of 949 companies
in the Biotechnology industry
Industry Median: -66.52 vs FRA:33M0: -3215.15


Rallybio OCF Margin % Related Terms


Rallybio OCF Margin % Historical Data

* Premium members only.

The historical data trend for Rallybio's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rallybio OCF Margin % Chart

Rallybio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 -7,748.74 -3,474.71

Rallybio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,813.68 -3,952.36 -3,089.62 -2,107.66 -3,763.21

FRA:33M0 vs VRCA, HRTX, CSBR: OCF Margin % Comparison

For the Biotechnology subindustry, Rallybio's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rallybio OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rallybio's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Rallybio's OCF Margin % falls into.


FRA:33M0
18GF Score
Rallybio Corp FRA:33M0
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rallybio OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Rallybio's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-29.813/0.858
=-3,474.71 %

Rallybio's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-7.978/0.212
=-3,763.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -3,763.21% mean?
Rallybio (FRA:33M0) has a OCF Margin % of -3,763.21% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rallybio and its competitors. According to the industry distribution chart, Rallybio ranks #831 out of 949 companies in the Biotechnology industry, placing it in the top 87.6%.
Is Rallybio's OCF Margin % too high?
Rallybio's current OCF Margin % is -3,763.21%. Based on the distribution chart, Rallybio ranks #831 out of 949 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Rallybio has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Rallybio's OCF Margin % compare to VRCA and HRTX?
According to the Biotechnology industry distribution chart, Rallybio ranks #831 out of 949 companies for OCF Margin %. This places Rallybio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rallybio and its competitors. Rallybio's current OCF Margin % is -3,763.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rallybio stock overvalued right now?
Rallybio (FRA:33M0) has a current OCF Margin % of -3,763.21%. The current OCF Margin % is -3,763.21%. Rallybio's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Rallybio (FRA:33M0), the current OCF Margin % is -3,763.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rallybio Business Description

Other Exchanges RLYB:USA
Address 234 Church Street, Suite 1020, New Haven, CT, USA, 06510
Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.
18GF Score

Get the complete analysis for FRA:33M0

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.90
Price